These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 7700165
21. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma. Spitz R, Hero B, Ernestus K, Berthold F. Med Pediatr Oncol; 2003 Jul; 41(1):30-5. PubMed ID: 12764740 [Abstract] [Full Text] [Related]
22. Clinical significance of genetic rearrangements in human neuroblastomas. Brodeur GM. Clin Chem; 1989 Jul; 35(7 Suppl):B38-42. PubMed ID: 2568197 [Abstract] [Full Text] [Related]
23. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma. Schleiermacher G, Peter M, Michon J, Hugot JP, Vielh P, Zucker JM, Magdelénat H, Thomas G, Delattre O. Genes Chromosomes Cancer; 1994 Aug; 10(4):275-81. PubMed ID: 7522542 [Abstract] [Full Text] [Related]
24. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M. Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179 [Abstract] [Full Text] [Related]
25. Analysis of genomic imprinting at 1p35-36 in neuroblastoma. Hogarty MD, Maris JM, White PS, Guo C, Brodeur GM. Med Pediatr Oncol; 2001 Jan 01; 36(1):52-5. PubMed ID: 11464906 [Abstract] [Full Text] [Related]
26. Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma. Maris JM, Guo C, White PS, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM. Med Pediatr Oncol; 2001 Jan 01; 36(1):24-7. PubMed ID: 11464895 [Abstract] [Full Text] [Related]
27. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Caron H, van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voûte PA, Westerveld A, Versteeg R. Nat Genet; 1993 Jun 01; 4(2):187-90. PubMed ID: 8102298 [Abstract] [Full Text] [Related]
28. Chromosome 1p allelic loss in neuroblastoma: prognosis, genomic imprinting and 1;17 translocations. Caron H, van Sluis P, van Roy N, Beks L, Maes P, Pereira do Tanque R, Slater R, de Kraker J, Speleman F, Voûte PA. Prog Clin Biol Res; 1994 Jun 01; 385():35-42. PubMed ID: 7972230 [No Abstract] [Full Text] [Related]
29. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma. Spitz R, Hero B, Ernestus K, Berthold F. Clin Cancer Res; 2003 Oct 15; 9(13):4835-40. PubMed ID: 14581355 [Abstract] [Full Text] [Related]
30. Prognostic relevance of genetic alterations in the p32 region of chromosome 1 in neuroblastoma. Avigad S, Benyaminy H, Tamir Y, Luria D, Yaniv I, Stein J, Stark B, Zaizov R. Eur J Cancer; 1997 Oct 15; 33(12):1983-5. PubMed ID: 9516838 [Abstract] [Full Text] [Related]
31. PCR assay for chromosome 1p deletion in small neuroblastoma samples. Peter M, Michon J, Vielh P, Neuenschwander S, Nakamura Y, Sonsino E, Zucker JM, Vergnaud G, Thomas G, Delattre O. Int J Cancer; 1992 Oct 21; 52(4):544-8. PubMed ID: 1399134 [Abstract] [Full Text] [Related]
32. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays. George RE, Attiyeh EF, Li S, Moreau LA, Neuberg D, Li C, Fox EA, Meyerson M, Diller L, Fortina P, Look AT, Maris JM. PLoS One; 2007 Feb 28; 2(2):e255. PubMed ID: 17327916 [Abstract] [Full Text] [Related]
33. Deletion mapping of chromosome 1p and 22q in pheochromocytoma. Shin E, Fujita S, Takami K, Kurahashi H, Kurita Y, Kobayashi T, Mori T, Nishisho I, Takai S. Jpn J Cancer Res; 1993 Apr 28; 84(4):402-8. PubMed ID: 8514606 [Abstract] [Full Text] [Related]
34. Chromosome 1p and 11q deletions and outcome in neuroblastoma. Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM, Children's Oncology Group. N Engl J Med; 2005 Nov 24; 353(21):2243-53. PubMed ID: 16306521 [Abstract] [Full Text] [Related]
35. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1. Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Fukuba I, Matsuura Y, Yokoyama T. Med Pediatr Oncol; 2001 Jan 24; 36(1):67-74. PubMed ID: 11464909 [Abstract] [Full Text] [Related]
36. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification. Cheng JM, Hiemstra JL, Schneider SS, Kaufman BA, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM. Prog Clin Biol Res; 1994 Jan 24; 385():43-9. PubMed ID: 7972236 [Abstract] [Full Text] [Related]
37. Loss of heterozygosity for chromosome 1p in familial neuroblastoma. Tonini GP, Lo Cunsolo C, Cusano R, Iolascon A, Dagnino M, Conte M, Milanaccio C, De Bernardi B, Mazzocco K, Scaruffi P. Eur J Cancer; 1997 Oct 24; 33(12):1953-6. PubMed ID: 9516831 [Abstract] [Full Text] [Related]
38. Peculiar allelotype associated with susceptibility to neuroblastoma. Perri P, Pession A, Mazzocco K, Strigini P, Iolascon A, Basso G, Tonini GP. Genes Chromosomes Cancer; 1996 Sep 24; 17(1):60-3. PubMed ID: 8889508 [Abstract] [Full Text] [Related]
39. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look AT, Enomoto H, Sakiyama S, Brodeur GM. Proc Natl Acad Sci U S A; 1995 Jun 06; 92(12):5520-4. PubMed ID: 7777541 [Abstract] [Full Text] [Related]